Biomerica (BMRA) Return on Sales (2016 - 2025)
Historic Return on Sales for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to 1.09%.
- Biomerica's Return on Sales fell 5100.0% to 1.09% in Q4 2025 from the same period last year, while for Nov 2025 it was 0.9%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.94% for FY2025, which is 1700.0% up from last year.
- Per Biomerica's latest filing, its Return on Sales stood at 1.09% for Q4 2025, which was down 5100.0% from 0.0% recorded in Q3 2025.
- Biomerica's 5-year Return on Sales high stood at 0.0% for Q3 2025, and its period low was 2.06% during Q2 2025.
- Its 5-year average for Return on Sales is 0.99%, with a median of 1.07% in 2025.
- As far as peak fluctuations go, Biomerica's Return on Sales skyrocketed by 12900bps in 2022, and later plummeted by -14700bps in 2023.
- Biomerica's Return on Sales (Quarter) stood at 0.24% in 2021, then plummeted by -353bps to 1.1% in 2022, then rose by 12bps to 0.96% in 2023, then soared by 40bps to 0.58% in 2024, then plummeted by -88bps to 1.09% in 2025.
- Its last three reported values are 1.09% in Q4 2025, 0.0% for Q3 2025, and 2.06% during Q2 2025.